Nurix Therapeutics, Inc. NRIX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$87.17M-11.4% | -$78.22M+9.5% | -$86.42M-98.8% | -$43.46M+22.9% | -$56.35M+3.8% | ||
| $2.2M+3.6% | $2.12M+4.5% | $2.03M-9.5% | $2.24M-4.6% | $2.35M-7.8% | ||
| $9.4M+3.5% | $9.09M-7.0% | $9.77M-5.9% | $10.39M+19.1% | $8.72M+2.5% | ||
| -$71.91M-6.0% | -$67.83M-18.2% | -$57.39M+9.1% | -$63.16M-3.4% | -$61.09M-25.3% | ||
| $1.05M-79.6% | $5.13M+89.3% | $2.71M+1.3% | $2.68M-23.2% | $3.49M+65.6% | ||
| -$123.83M-35,888% | $346K-99.3% | $50.48M-29.4% | $71.5M+180% | $25.53M+118% | ||
| $19.98M-91.5% | $236.01M+20,334% | $1.16M+19,150% | $6K-99.6% | $1.47M-99.3% | ||
| -$175.77M-204% | $168.52M+3,028% | -$5.76M-169% | $8.34M+124% | -$34.08M-411% | ||
| -$72.96M0.0% | -$72.96M-21.4% | -$60.1M+8.7% | -$65.84M-2.0% | -$64.57M-27.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nurix Therapeutics, Inc. generate?
- Nurix Therapeutics, Inc. (NRIX) generated -$260.3M in operating cash flow over the trailing twelve months.
- What is Nurix Therapeutics, Inc.'s free cash flow?
- After $11.6M of capital expenditures, Nurix Therapeutics, Inc.'s free cash flow was -$271.9M over the trailing twelve months, down 34.8% year over year.
- Where does Nurix Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Nurix Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
